Cargando…
ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer
c‐Ros oncogene 1, receptor tyrosine kinase (ROS1) genomic rearrangements have been reported previously in rare cases of colorectal cancer (CRC), yet little is known about the frequency, molecular characteristics, and therapeutic vulnerabilities of ROS1‐driven CRC. We analyzed a clinical dataset of 4...
Autores principales: | Akhoundova, Dilara, Hussung, Saskia, Sivakumar, Smruthy, Töpfer, Antonia, Rechsteiner, Markus, Kahraman, Abdullah, Arnold, Fabian, Angst, Florian, Britschgi, Christian, Zoche, Martin, Moch, Holger, Weber, Achim, Sokol, Ethan, Fritsch, Ralph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804412/ https://www.ncbi.nlm.nih.gov/pubmed/36053834 http://dx.doi.org/10.1002/ijc.34257 |
Ejemplares similares
-
MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards
por: Kahraman, Abdullah, et al.
Publicado: (2022) -
Targeting ALK in Neuroendocrine Tumors of the Lung
por: Akhoundova, Dilara, et al.
Publicado: (2022) -
Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
por: Hussung, Saskia, et al.
Publicado: (2021) -
STRN-ALK Rearranged Malignant Peritoneal Mesothelioma With Dramatic Response Following Ceritinib Treatment
por: Rüschoff, Jan H., et al.
Publicado: (2019) -
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms
por: Haberecker, Martina, et al.
Publicado: (2022)